Infiltration, block, caudal, epidural, lumbor anaesthesia with long duration of action.
Max. dose is 150 mg in a 4-hour period.
Intravenous regional anaes-thesia. Digital block.
Cardiovascular diseases, Elderly, debilitated patients. Shock, heart block, hepatic impairment. Drug interaction occurs with phenothiazines, MAOIS, general anaesthetics. Paediatrics: Not recommended below age 12 years. Pregnancy: Use only, if clearly indicated. Lactation: Use with caution. Elderly: Reduced dose necessary.
Cardiac arrests, CNS depression, apnoea, hypotension, bradycardia, arrhythmias, persistent neurological deficits despite anaesthetic recovery. Allergy/angioneurotic oedema/ rashes/ laryngeal oedema/ pyrexia.
May potentiate systemic toxicity of other amide local anaesthetics, lignocaine and mepivacaine. Reduced clearance with cimetidine and ranitidine.
|Brand Name||Manufactured by|
|MARCAIN||NICHOLAS PIRAMAL INDIA|
|SENSORCAINE||ASTRA ZENECA PHARMA INDIA LTD.|
|SENSORCAINE HEAVY||ASTRA ZENECA PHARMA INDIA LTD.|